Noam Krantz, an accomplished business professional, has an extensive background in finance and biology. As a lifelong learner, he holds a Master of Business Administration in Finance from Columbia Business School and a Bachelor of Science in Biology from the UC Santa Barbara. Krantz's work experience encompasses many prominent organizations, including Johnson & Johnson Innovation JJDC Inc., Ethicon, Inc., Mentor Worldwide, Inamed Corporation, and Bear Stearns & Co.

As the Vice President of Venture Investing at Johnson & Johnson Innovation JJDC Inc., Krantz oversees venture capital investments and helps to build companies that advance human health. Before joining JJDC, Krantz served as the World Wide Vice President of Business Development at Ethicon, Inc., a subsidiary of Johnson & Johnson, where he played a significant role in executing strategic transactions for the organization. He also held leadership positions in Corporate Development at Mentor Worldwide, a subsidiary of Johnson & Johnson, and Inamed Corporation, where he oversaw M&A and licensing activities.

Krantz began his career as an Associate Investment Banker at Bear Stearns & Co., where he worked on mergers and acquisitions, equity offerings, and debt financings for healthcare clients. His vast expertise, knowledge of the health care industry, and strategic insights have earned him a reputation as a dynamic business leader.